Fortive is a scientific & technical instruments business based in the US. Fortive shares (FTV) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $53.45 – an increase of 0.41% over the previous week. Fortive employs 18,000 staff and has a trailing 12-month revenue of around $6.3 billion.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Fortive stock price (NYSE: FTV)
Use our graph to track the performance of FTV stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Fortive price performance over time
Historical closes compared with the close of $53.14 from 2025-12-02
1 week (2025-11-26)
-0.17%
1 month (2025-11-04)
5.56%
3 months (2025-09-04)
11.69%
6 months (2025-06-04)
-26.11%
1 year (2024-12-04)
-32.59%
2 years (2023-12-04)
-23.26%
3 years (2022-12-02)
67.6717
5 years (2020-12-04)
1.18%
Is Fortive stock undervalued or overvalued?
Valuing Fortive stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fortive's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fortive's P/E ratio
Fortive's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, Fortive shares trade at around 21x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Fortive's PEG ratio
Fortive's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2896. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fortive's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fortive's EBITDA
Fortive's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.7 billion.
The EBITDA is a measure of a Fortive's overall financial performance and is widely used to measure a its profitability.
Fortive financials
Revenue TTM
$6.3 billion
Operating margin TTM
15.54%
Gross profit TTM
$3.7 billion
Return on assets TTM
4.83%
Return on equity TTM
10.36%
Profit margin
9.62%
Book value
$20.48
Market Capitalization
$18.1 billion
TTM: trailing 12 months
Fortive share dividends
Dividend payout ratio: 9.36% of net profits
Recently Fortive has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fortive shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Fortive's case, that would currently equate to about $0.3 per share.
While Fortive's payout ratio might seem low, this can signify that Fortive is investing more in its future growth.
Fortive's most recent dividend payout was on 25 December 2025. The latest dividend was paid out to all shareholders who bought their shares by 27 November 2025 (the "ex-dividend date").
Have Fortive's shares ever split?
Fortive's shares were
split on a 1327:1000 basis on 29 June 2025
. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1327 shares. This wouldn't directly have changed the overall worth of your Fortive shares – just the quantity. However, indirectly, the new 24.6% lower share price could have impacted the market appetite for Fortive shares which in turn could have impacted Fortive's share price.
Fortive share price volatility
Over the last 12 months, Fortive's shares have ranged in value from as little as $45.2865 up to $62.424. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Fortive's is 1.05. This would suggest that Fortive's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Fortive overview
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington. .
Frequently asked questions
null What percentage of Fortive is owned by insiders or institutions? Currently 0.347% of Fortive shares are held by insiders and 103.254% by institutions.How many people work for Fortive? Latest data suggests 18,000 work at Fortive.When does the fiscal year end for Fortive? Fortive's fiscal year ends in December.Where is Fortive based? Fortive's address is: 6920 Seaway Boulevard, Everett, WA, United States, 98203What is Fortive's ISIN number? Fortive's international securities identification number is: US34959J1088What is Fortive's CUSIP number? Fortive's Committee on Uniform Securities Identification Procedures number is: 34959J108
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
